Driving Commercial Excellence, Customer Partnerships and Market Impact
At Shionogi, we are committed to improving global health through innovation, collaboration and scientific excellence. As our European organisation continues to expand, we are strengthening our commercial capabilities to drive sustainable growth and maximise value for patients and healthcare systems.
We are now seeking a Key Account Manager to join our Spanish Affiliate. This is a critical, customer-facing role with responsibility for managing key hospital accounts, driving product adoption, and delivering strong commercial performance across Spain.
Why Join Shionogi?
Shionogi offers a purpose-driven, agile environment where individuals are empowered to make a meaningful impact. This role provides the opportunity to work cross-functionally, build strategic customer partnerships, and contribute directly to commercial success within a growing European business.
About the Role
As Key Account Manager, you will be responsible for leading account management and commercial execution across your territory, with a strong focus on optimising product positioning within hospital settings.
Key responsibilities include:
What Are We Looking For?
We are looking for a commercially driven and customer-focused professional who can operate effectively in a field-based, high-impact role.
You will bring:
Join Us
Join Shionogi and play a key role in delivering commercial success across Spain. If you are motivated by customer impact, strategic account management and working within a growing European organisation, we would welcome your application.

Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19.
Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology.
Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide.
See our community guidelines: https://bit.ly/4n3Jhe4